The German Institute for Quality and Efficiency in Health Care (IQWiG) has responded critically to a reflection paper by the European Medicines Agency (EMA) on the approval of new drugs based on single-arm studies.
Oct 6, 2023
0
7
The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation ...
Oct 2, 2023
0
8
A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.
Sep 29, 2023
0
3
Lenacapavir, an injection, has been approved by the FDA for multi-drug resistant HIV.
Sep 1, 2023
0
23
The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent ...
Aug 24, 2023
1
99
The U.S. Food & Drug Administration has approved Akeega (niraparib and abiraterone acetate) for the treatment of BRCA-positive metastatic castration-resistant prostate cancer.
Aug 18, 2023
0
2
A new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion. In an evaluation of the device, UC San Francisco researchers ...
Aug 12, 2023
0
46
Karen Butcher, whose son died in 2020 of an opioid overdose, asked a panel of experts on Monday in Frankfort: If cost wasn't a factor, why shouldn't Kentucky explore the use of an illicit psychedelic drug as a treatment for ...
Jul 23, 2023
1
35
The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin disease—both the result ...
Jun 27, 2023
0
15
